🇺🇸 FDA
Pipeline program

GEN1042

GCT1042-03

Phase 1 mab active

Quick answer

GEN1042 for Malignant Solid Tumor is a Phase 1 program (mab) at Genmab A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Genmab A/S
Indication
Malignant Solid Tumor
Phase
Phase 1
Modality
mab
Status
active

Clinical trials